Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 782

1.

Patient-centered medical homes and preventive service use.

Farley JF, Kumar A, Urick BY, Domino ME.

Am J Manag Care. 2019 May 1;25(5):e153-e159.

2.

Cardiovascular risk prevalence in South Africans with drug-resistant tuberculosis: a cross-sectional study.

Whitehouse ER, Perrin N, Levitt N, Hill M, Farley JE.

Int J Tuberc Lung Dis. 2019 May 1;23(5):587-593. doi: 10.5588/ijtld.18.0374.

PMID:
31097067
3.

Fondaparinux Sodium Compared With Low-Molecular-Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta-analysis.

Kumar A, Talwar A, Farley JF, Muzumdar J, Schommer JC, Balkrishnan R, Wu W.

J Am Heart Assoc. 2019 May 21;8(10):e012184. doi: 10.1161/JAHA.119.012184.

4.

Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment.

Hong H, Dooley KE, Starbird LE, Francis HW, Farley JE.

Arch Toxicol. 2019 May;93(5):1385-1399. doi: 10.1007/s00204-019-02407-8. Epub 2019 Apr 8.

PMID:
30963202
5.

Aminoglycoside-Induced Hearing Loss Among Patients Being Treated for Drug-Resistant Tuberculosis in South Africa: A Prediction Model.

Hong H, Dowdy DW, Dooley KE, Francis HW, Budhathoki C, Han HR, Farley JE.

Clin Infect Dis. 2019 Apr 9. pii: ciz289. doi: 10.1093/cid/ciz289. [Epub ahead of print]

PMID:
30963176
6.

Do comprehensive medication review completion rates predict medication use and management quality?

Wang Y, Farley JF, Ferreri SP, Renfro CP.

Res Social Adm Pharm. 2019 Apr;15(4):417-424. doi: 10.1016/j.sapharm.2018.06.010. Epub 2018 Jun 20.

PMID:
30917893
7.

Characterizing and assessing antiemetic underuse in patients initiating highly emetogenic chemotherapy.

Mahendraratnam N, Farley JF, Basch E, Proctor A, Wheeler SB, Dusetzina SB.

Support Care Cancer. 2019 Mar 26. doi: 10.1007/s00520-019-04730-3. [Epub ahead of print]

PMID:
30915567
8.

Acceptability of self-collecting oropharyngeal swabs for sexually transmissible infection testing among men and women.

Dangerfield DT, Farley JE, Holden J, Barnes M, Barnes P, Jett-Goheen M, Gaydos C.

Sex Health. 2019 Mar 22. doi: 10.1071/SH18209. [Epub ahead of print]

PMID:
30898197
9.

Improvements in the HIV care continuum needed to meaningfully reduce HIV incidence among men who have sex with men in Baltimore, US: a modelling study for HPTN 078.

Mitchell KM, Hoots B, Dimitrov D, German D, Flynn C, Farley JE, Gelman M, Hughes JP, Donnell D, Adeyeye A, Remien RH, Beyrer C, Paz-Bailey G, Boily MC.

J Int AIDS Soc. 2019 Mar;22(3):e25246. doi: 10.1002/jia2.25246.

10.

Preferences for an HIV prevention mobile phone app: a qualitative study among men who have sex with men in China.

Zhang A, Reynolds NR, Farley JE, Wang X, Tan S, Yan J.

BMC Public Health. 2019 Mar 12;19(1):297. doi: 10.1186/s12889-019-6617-4.

11.

Do enhanced services pharmacies serve sicker patients?

Urick BY, Farley JF.

J Am Pharm Assoc (2003). 2019 Mar - Apr;59(2):280-284. doi: 10.1016/j.japh.2018.12.008. Epub 2019 Feb 1.

PMID:
30713081
12.

Assessment of the Perceived Acceptability of an Early Enrollment Strategy Using Advance Consent in Health Care-Associated Pneumonia.

Corneli A, Perry B, Collyar D, Powers JH 3rd, Farley JJ, Calvert SB, Santiago J, Donnelly HK, Swezey T, Dombeck CB, De Anda C, Fowler VG Jr, Holland TL.

JAMA Netw Open. 2018 Dec 7;1(8):e185816. doi: 10.1001/jamanetworkopen.2018.5816.

13.

Siyaphambili protocol: An evaluation of randomized, nurse-led adaptive HIV treatment interventions for cisgender female sex workers living with HIV in Durban, South Africa.

Comins CA, Schwartz SR, Phetlhu DR, Guddera V, Young K, Farley JE, West N, Parmley L, Geng E, Beyrer C, Dowdy D, Mishra S, Hausler H, Baral S.

Res Nurs Health. 2019 Apr;42(2):107-118. doi: 10.1002/nur.21928. Epub 2019 Jan 15.

PMID:
30644999
14.

The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing PrEP Regimens in Men who have Sex with Men.

McGowan I, Wilkin T, Landovitz RJ, Wu C, Chen Y, Marzinke MA, Hendrix CW, Richardson P, Eshleman SH, Andrade A, Chege W, Anderson PL, McCauley M, Farley J, Mayer KH, Anton P, Brand RM, Cranston RD, Gulick R.

AIDS. 2018 Dec 13. doi: 10.1097/QAD.0000000000002038. [Epub ahead of print]

PMID:
30570571
15.

The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM.

McGowan I, Wilkin T, Landovitz RJ, Wu C, Chen Y, Marzinke MA, Hendrix CW, Richardson P, Eshleman SH, Andrade A, Chege W, Anderson PL, McCauley M, Farley J, Mayer KH, Anton P, Brand RM, Cranston RD, Gulick R.

AIDS. 2019 Feb 1;33(2):237-246. doi: 10.1097/QAD.0000000000002038.

PMID:
30557160
16.

Lessons Learned from Using Global Outcome Measures to Assess Community Pharmacy Performance.

Urick BY, Ferreri SP, Shasky C, Pfeiffenberger T, Trygstad T, Farley JF.

J Manag Care Spec Pharm. 2018 Dec;24(12):1278-1283. doi: 10.18553/jmcp.2018.24.12.1278.

17.

Accounting for environmental and observer effects in estimating abundance of southern bluefin tuna from aerial survey data.

Eveson JP, Bravington MV, Farley JH.

PLoS One. 2018 Nov 26;13(11):e0207790. doi: 10.1371/journal.pone.0207790. eCollection 2018.

18.

High biodiversity silvopastoral system as an alternative to improve the thermal environment in the dairy farms.

Deniz M, Schmitt Filho AL, Farley J, de Quadros SF, Hötzel MJ.

Int J Biometeorol. 2019 Jan;63(1):83-92. doi: 10.1007/s00484-018-1638-8. Epub 2018 Nov 19.

PMID:
30456653
19.

Provision of guideline-based care for drug-resistant tuberculosis in South Africa: Level of concordance between prescribing practices and guidelines.

van de Water BJ, Silva SG, Prvu Bettger J, Humphreys J, Cunningham CK, Farley JE.

PLoS One. 2018 Nov 5;13(11):e0203749. doi: 10.1371/journal.pone.0203749. eCollection 2018.

20.

Pediatric Antibacterial and Antifungal Trials From 2007 to 2017.

Thaden JT, Chiswell K, Jaffe I, Bergin SP, Yang WE, Romaine A, Roberts J, Nambiar S, Farley J, Benjamin DK Jr, Smith PB, Tsalik EL.

Pediatrics. 2018 Sep;142(3). pii: e20171849. doi: 10.1542/peds.2017-1849.

PMID:
30158197
21.

Care2Cure: A randomized controlled trial protocol for evaluating nurse case management to improve the hepatitis C care continuum within HIV primary care.

Starbird LE, Han HR, Sulkowski MS, Budhathoki C, Reynolds NR, Farley JE.

Res Nurs Health. 2018 Oct;41(5):417-427. doi: 10.1002/nur.21903. Epub 2018 Aug 28.

PMID:
30152537
22.

Effectiveness of macronutrient supplementation on nutritional status and HIV/AIDS progression: A systematic review and meta-analysis.

Hong H, Budhathoki C, Farley JE.

Clin Nutr ESPEN. 2018 Oct;27:66-74. doi: 10.1016/j.clnesp.2018.06.007. Epub 2018 Jul 6.

PMID:
30144895
23.

Do Medical Homes Improve Quality of Care for Persons with Multiple Chronic Conditions?

Swietek KE, Domino ME, Beadles C, Ellis AR, Farley JF, Grove LR, Jackson C, DuBard CA.

Health Serv Res. 2018 Dec;53(6):4667-4681. doi: 10.1111/1475-6773.13024. Epub 2018 Aug 7.

PMID:
30088272
24.

Testing the organizational theory of innovation implementation effectiveness in a community pharmacy medication management program: a hurdle regression analysis.

Turner K, Trogdon JG, Weinberger M, Stover AM, Ferreri S, Farley JF, Ray N, Patti M, Renfro C, Shea CM.

Implement Sci. 2018 Jul 31;13(1):105. doi: 10.1186/s13012-018-0799-5.

25.

A systematic review of the effectiveness of smoking cessation interventions among patients with tuberculosis.

Whitehouse E, Lai J, Golub JE, Farley JE.

Public Health Action. 2018 Jun 21;8(2):37-49. doi: 10.5588/pha.18.0006. Review.

26.

Increased risk of aminoglycoside-induced hearing loss in MDR-TB patients with HIV coinfection.

Hong H, Budhathoki C, Farley JE.

Int J Tuberc Lung Dis. 2018 Jun 1;22(6):667-674. doi: 10.5588/ijtld.17.0830.

27.
28.

Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001).

Konstantinopoulos PA, Brady WE, Farley J, Armstrong A, Uyar DS, Gershenson DM.

Gynecol Oncol. 2018 Jul;150(1):9-13. doi: 10.1016/j.ygyno.2018.04.572. Epub 2018 May 5.

PMID:
29739622
29.

Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation Initiative.

Greenberg RG, Corneli A, Bradley J, Farley J, Jafri HS, Lin L, Nambiar S, Noel GJ, Wheeler C, Tiernan R, Smith PB, Roberts J, Benjamin DK Jr.

Contemp Clin Trials Commun. 2017 Nov 26;9:7-12. doi: 10.1016/j.conctc.2017.11.006. eCollection 2018 Mar.

30.

Community health worker interventions to promote psychosocial outcomes among people living with HIV-A systematic review.

Han HR, Kim K, Murphy J, Cudjoe J, Wilson P, Sharps P, Farley JE.

PLoS One. 2018 Apr 24;13(4):e0194928. doi: 10.1371/journal.pone.0194928. eCollection 2018. Review.

31.

Simultaneous assessment of cognitive function, circadian rhythm, and spontaneous activity in aging mice.

Logan S, Owen D, Chen S, Chen WJ, Ungvari Z, Farley J, Csiszar A, Sharpe A, Loos M, Koopmans B, Richardson A, Sonntag WE.

Geroscience. 2018 Apr;40(2):123-137. doi: 10.1007/s11357-018-0019-x. Epub 2018 Apr 24.

32.

Continuity of Medication Management among Adults with Schizophrenia and Comorbid Cardiometabolic Conditions.

Hansen RA, Hohmann N, Maciejewski ML, Domino ME, Ray N, Mahendraratnam N, Farley JF.

J Pharm Health Serv Res. 2018 Mar;9(1):13-20. doi: 10.1111/jphs.12201. Epub 2017 Nov 20.

33.

Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-β uptake in astrocytes.

Logan S, Pharaoh GA, Marlin MC, Masser DR, Matsuzaki S, Wronowski B, Yeganeh A, Parks EE, Premkumar P, Farley JA, Owen DB, Humphries KM, Kinter M, Freeman WM, Szweda LI, Van Remmen H, Sonntag WE.

Mol Metab. 2018 Mar;9:141-155. doi: 10.1016/j.molmet.2018.01.013. Epub 2018 Feb 2.

34.

Impact of intimate partner violence on clinic attendance, viral suppression and CD4 cell count of women living with HIV in an urban clinic setting.

Anderson JC, Campbell JC, Glass NE, Decker MR, Perrin N, Farley J.

AIDS Care. 2018 Apr;30(4):399-408. doi: 10.1080/09540121.2018.1428725.

35.

TB Risk Perceptions among Medical Residents at a Tertiary Care Center in India.

Pardeshi GS, Kadam D, Chandanwale A, Deluca A, Khobragade P, Parande M, Suryavanshi N, Kinikar A, Basavaraj A, Girish S, Shelke S, Gupte N, Farley J, Bollinger R.

Tuberc Res Treat. 2017;2017:7514817. doi: 10.1155/2017/7514817. Epub 2017 Nov 22.

36.

Transcription factor Pebbled/RREB1 regulates injury-induced axon degeneration.

Farley JE, Burdett TC, Barria R, Neukomm LJ, Kenna KP, Landers JE, Freeman MR.

Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):1358-1363. doi: 10.1073/pnas.1715837115. Epub 2018 Jan 2.

37.

Time to Drug-Resistant Tuberculosis Treatment in a Prospective South African Cohort.

van de Water BJ, Prvu Bettger J, Silva S, Humphreys J, Cunningham CK, Farley JE.

Glob Pediatr Health. 2017 Nov 30;4:2333794X17744140. doi: 10.1177/2333794X17744140. eCollection 2017.

38.

Identifying models of HIV care and treatment service delivery in Tanzania, Uganda, and Zambia using cluster analysis and Delphi survey.

Tsui S, Denison JA, Kennedy CE, Chang LW, Koole O, Torpey K, Van Praag E, Farley J, Ford N, Stuart L, Wabwire-Mangen F.

BMC Health Serv Res. 2017 Dec 6;17(1):811. doi: 10.1186/s12913-017-2772-4.

39.

Sexual Positioning Practices and Sexual Risk Among Black Gay and Bisexual Men: A Life Course Perspective.

Dangerfield DT 2nd, Smith LR, Anderson JN, Bruce OJ, Farley J, Bluthenthal R.

AIDS Behav. 2018 Jun;22(6):1919-1931. doi: 10.1007/s10461-017-1948-6.

40.

Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.

Fang G, Annis IE, Farley JF, Mahendraratnam N, Hickson RP, Stürmer T, Robinson JG.

Pharmacotherapy. 2018 Jan;38(1):29-41. doi: 10.1002/phar.2051. Epub 2017 Dec 11.

41.

Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients-An analysis from the Brazilian Hodgkin Lymphoma Registry.

Biasoli I, Castro N, Delamain M, Silveira T, Farley J, Pinto Simões B, Solza C, Praxedes M, Baiocchi O, Gaiolla R, Franceschi F, Bonamin Sola C, Boquimpani C, Clementino N, Fleury Perini G, Pagnano K, Steffenello G, Tabacof J, de Freitas Colli G, Soares A, de Souza C, Chiattone CS, Raggio Luiz R, Milito C, Morais JC, Spector N.

Int J Cancer. 2018 Mar 1;142(5):883-890. doi: 10.1002/ijc.31096. Epub 2017 Oct 26.

42.

EXPANDING INFANT MENTAL HEALTH TREATMENT SERVICES TO AT-RISK PRESCHOOLERS AND THEIR FAMILIES THROUGH THE INTEGRATION OF RELATIONAL PLAY THERAPY.

Farley JL, Whipple EE.

Infant Ment Health J. 2017 Sep;38(5):669-679. doi: 10.1002/imhj.21663. Epub 2017 Aug 21.

PMID:
28833296
43.

An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.

Oliver KE, Brady WE, Birrer M, Gershenson DM, Fleming G, Copeland LJ, Tewari K, Argenta PA, Mannel RS, Secord AA, Stephan JM, Mutch DG, Stehman FB, Muggia FM, Rose PG, Armstrong DK, Bookman MA, Burger RA, Farley JH.

Gynecol Oncol. 2017 Nov;147(2):243-249. doi: 10.1016/j.ygyno.2017.08.004. Epub 2017 Aug 12.

44.

Do Medical Homes Offer Improved Diabetes Care for Medicaid Enrollees with Co-occurring Schizophrenia?

Olesiuk WJ, Farley JF, Domino ME, Ellis AR, Morrissey JP.

J Health Care Poor Underserved. 2017;28(3):1030-1041. doi: 10.1353/hpu.2017.0094.

45.

From Metacognition to Practice Cognition: The DNP e-Portfolio to Promote Integrated Learning.

Anderson KM, DesLauriers P, Horvath CH, Slota M, Farley JN.

J Nurs Educ. 2017 Aug 1;56(8):497-500. doi: 10.3928/01484834-20170712-09.

PMID:
28787073
46.

Evaluation of a nurse practitioner-physician task-sharing model for multidrug-resistant tuberculosis in South Africa.

Farley JE, Ndjeka N, Kelly AM, Whitehouse E, Lachman S, Budhathoki C, Lowensen K, Bergren E, Mabuza H, Mlandu N, van der Walt M.

PLoS One. 2017 Aug 4;12(8):e0182780. doi: 10.1371/journal.pone.0182780. eCollection 2017.

47.

Evaluating the potential for primary care to serve as a mental health home for people with schizophrenia.

Grove LR, Olesiuk WJ, Ellis AR, Lichstein JC, DuBard CA, Farley JF, Jackson CT, Beadles CA, Morrissey JP, Domino ME.

Gen Hosp Psychiatry. 2017 Jul;47:14-19. doi: 10.1016/j.genhosppsych.2017.03.002. Epub 2017 Mar 7.

48.

Neural Interaction Between Risk Sensitivity and Cognitive Control Predicting Health Risk Behaviors Among Late Adolescents.

Kim-Spoon J, Deater-Deckard K, Lauharatanahirun N, Farley JP, Chiu PH, Bickel WK, King-Casas B.

J Res Adolesc. 2017 Sep;27(3):674-682. doi: 10.1111/jora.12295. Epub 2016 Nov 16.

49.

CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary intervention.

Borse MS, Dong OM, Polasek MJ, Farley JF, Stouffer GA, Lee CR.

Pharmacogenomics. 2017 Aug;18(12):1155-1166. doi: 10.2217/pgs-2017-0075. Epub 2017 Jul 26.

50.

Methodologic considerations of household-level methicillin-resistant Staphylococcus aureus decolonization among persons living with HIV.

Farley JE, Starbird LE, Anderson J, Perrin NA, Lowensen K, Ross T, Carroll KC.

Am J Infect Control. 2017 Oct 1;45(10):1074-1080. doi: 10.1016/j.ajic.2017.05.010. Epub 2017 Jul 3.

Supplemental Content

Loading ...
Support Center